Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Not Yet Recruiting NCT07824973

Ketamine Treatment for Treatment-Resistant Depression - the Role of Framing

Conditions: Treatment Resistant Depression (TRD)

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: No

Phase: NA

Enrollment: 120

Sponsor: Valdemar Landgren

Location: Brain Stimulation Clinic, Skaraborg's Hospital Skövde Västra Götaland County

Summary

Ketamine is a medicine used in psychiatry for treatment-resistant depression. This study compares two ways of framing ketamine treatment: a psychedelic framing and a biomedical framing. The study will examine whether the framing affects depressive symptoms, treatment experience, tolerability, and longer-term outcomes.

Eligibility Criteria

Inclusion Criteria: * Prescribed ketamine treatment for depression * Able to understand study information and provide informed consent Exclusion Criteria: \- Patients who do not meet the inclusion criteria

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07824973). StuddyBuddy aggregates publicly available trial information.